quinazolines has been researched along with carbostyril in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (9.09) | 18.7374 |
| 1990's | 3 (9.09) | 18.2507 |
| 2000's | 12 (36.36) | 29.6817 |
| 2010's | 12 (36.36) | 24.3611 |
| 2020's | 3 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Kano, Y; Komatsu, K; Qine, Z | 1 |
| Alvarez, R; Kenley, RA; Lin, LH; Venuti, MC; Visor, GC | 1 |
| Alvarez, R; Berks, AH; Bruno, JJ; Jones, GH; Prince, A; Venuti, MC | 1 |
| Beretz, A; Cazenave, JP; Corre, G; Lanza, F; Stierlé, A | 1 |
| Dousa, TP; Grande, JP; Matousovic, K; Tsuboi, Y; Walker, H | 1 |
| Daugschies, A; Gässlein, U; Rommel, M | 1 |
| Aubry, AF; Gray, V; Hobson, T; Rabel, S; Sebastian, D; Xie, M; Xu, JQ | 1 |
| Gras, S; Hill, BT; Perrin, D; van Hille, B | 1 |
| Barrie, E; Kelland, LR; Rowlands, MG; Smith, V; Workman, P | 1 |
| Sánchez De Cos Escuín, J | 1 |
| Doherty, JB; Hop, CE; Hunt, JA; Ita, I; Kallashi, F; Kumar, S; McCormick, SX; O'Keefe, SJ; O'Neill, EA; Pivnichny, JV; Porter, G; Ruzek, RD; Sinclair, PJ; Thompson, JE; Wang, Z; Woods, A; Zaller, DM | 1 |
| Angibaud, P; Bourdrez, X; Devine, A; End, DW; Freyne, E; Ligny, Y; Mannens, G; Muller, P; Pilatte, I; Poncelet, V; Skrzat, S; Smets, G; Van Dun, J; Van Remoortere, P; Venet, M; Wouters, W | 1 |
| Khuri, FR | 1 |
| Angibaud, P; Bourdrez, X; Damsch, S; End, DW; Freyne, E; Janicot, M; Lezouret, P; Ligny, Y; Mannens, G; Mevellec, L; Meyer, C; Muller, P; Pilatte, I; Poncelet, V; Roux, B; Smets, G; Van Dun, J; Van Remoortere, P; Venet, M; Wouters, W | 1 |
| Blackburn, C; Brodjian, S; Brown, J; Che, JL; Collins, CA; Cullis, CA; Dayton, B; Doherty, C; Geddes, B; Govek, E; Kadambi, V; Kym, PR; Lai, S; LaMarche, MJ; Maguire, M; Marsh, KC; Marsilje, T | 1 |
| Borner, MM | 1 |
| Filov, VA; Gershanovich, ML; Imianitov, EN; Stukov, AN | 1 |
| Agarwal, SK; Burman, AC; Jha, A; Mukherjee, R; Srivastava, SK | 1 |
| Chen, JJ; Hwang, TL; Kuo, YH; Wang, TY; Wu, JB | 1 |
| Doçi, CL; Hasina, R; Lingen, MW; Mankame, TP; Wroblewski, K; Zhou, G | 1 |
| Boyett, JM; Geyer, R; Haas-Kogan, D; Kieran, MW; Kun, L; Ng, S; Pollack, IF; Poussaint, TY; Prabhu, SP; Vajapeyam, S | 1 |
| Boyett, JM; Cha, S; Geyer, R; Haas-Kogan, D; Kocak, M; Kun, LE; Packer, RI; Patay, Z; Pollack, IF; Poussaint, TY; Robertson, RL; Vajapeyam, S; Vezina, G; Zimmerman, R | 1 |
| Bear, CE; Kim Chiaw, P; Yu, W | 1 |
| Belavic, JM | 1 |
| Chaumais, MC; De Man, FS; Dorfmüller, P; Eddahibi, S; Fadel, E; François, C; Girerd, B; Guignabert, C; Huertas, A; Humbert, M; Lecerf, F; Montani, D; Perros, F; Tu, L | 1 |
| Cho, NJ; Park, YS | 1 |
| Cho, BC; Kim, HR; Lim, SM; Shim, HS; Soo, RA | 1 |
| Erba, HP | 1 |
| Bhakta, S; Bucar, F; Evangelopoulos, D; Guzman, JD; Hochfellner, C; Kunert, O; McHugh, TD; Wube, A; Zloh, M | 1 |
| Guo, M; He, J; Jiang, X; Jiang, Y; Li, J; Liu, J; Ouyang, L; Wang, J; Zhang, J; Zhang, S | 1 |
| Bagal, SK; Bickerton, S; Bodnarchuk, MS; Breed, J; Carbajo, RJ; Cassar, DJ; Chakraborty, A; Cosulich, S; Cumming, I; Davies, M; Eatherton, A; Evans, L; Feron, L; Fillery, S; Gleave, ES; Goldberg, FW; Hanson, L; Harlfinger, S; Howard, M; Howells, R; Jackson, A; Kemmitt, P; Kettle, JG; Kingston, JK; Lamont, S; Lewis, HJ; Li, S; Liu, L; Ogg, D; Phillips, C; Polanski, R; Robb, G; Robinson, D; Ross, S; Smith, JM; Tonge, M; Whiteley, R; Yang, J; Zhang, L; Zhao, X | 1 |
| Kwon, M; Lee, DW; Lee, HN; Lee, W | 1 |
| Jiang, X; Li, D; Li, Y; Liu, W; Zhao, Q | 1 |
9 review(s) available for quinazolines and carbostyril
| Article | Year |
|---|---|
[New therapeutic targets and strategies in lung cancer].
Topics: Alkyl and Aryl Transferases; Angiogenesis Inhibitors; Antineoplastic Agents; Benzamides; Benzodiazepines; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Endothelial Growth Factors; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Erlotinib Hydrochloride; Farnesyltranstransferase; Gefitinib; Humans; Imatinib Mesylate; Imidazoles; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Lymphokines; Metalloendopeptidases; Multicenter Studies as Topic; Piperazines; Polyisoprenyl Phosphates; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Quinolones; Randomized Controlled Trials as Topic; Receptor Protein-Tyrosine Kinases; Sesquiterpenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Primary and secondary prevention of non-small-cell lung cancer: the SPORE Trials of Lung Cancer Prevention.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Chemoprevention; Clinical Trials as Topic; Disease Progression; Epidermal Growth Factor; Gefitinib; Humans; Lung Neoplasms; Precancerous Conditions; Protein-Tyrosine Kinases; Quinazolines; Quinolones | 2003 |
[Molecular targets in colon cancer].
Topics: Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Camptothecin; Cetuximab; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Colonic Neoplasms; Drug Delivery Systems; ErbB Receptors; Gefitinib; Humans; Imatinib Mesylate; Indoles; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Phthalazines; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Quinolones; Receptors, Platelet-Derived Growth Factor; Receptors, Somatomedin; Signal Transduction; Sirolimus; Sunitinib | 2006 |
[Problems in the current target therapy of malignancies].
Topics: Alemtuzumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Agents; Azathioprine; Benzamides; Bevacizumab; Cetuximab; Erlotinib Hydrochloride; Gefitinib; Humans; Imatinib Mesylate; Neoplasms; Phthalazines; Piperazines; Pyridines; Pyrimidines; Quinazolines; Quinolones; Rituximab; Sesquiterpenes; Sesquiterpenes, Guaiane; Trastuzumab | 2005 |
Synthesis and structure-activity relationships of potent antitumor active quinoline and naphthyridine derivatives.
Topics: Antineoplastic Agents; Humans; Immunologic Factors; Naphthyridines; Quinazolines; Quinolines; Quinolones; Structure-Activity Relationship | 2007 |
Role of FGF receptors as an emerging therapeutic target in lung squamous cell carcinoma.
Topics: Alanine; Antineoplastic Agents; Benzimidazoles; Carcinoma, Squamous Cell; Gene Amplification; Humans; Lung Neoplasms; Molecular Targeted Therapy; Quinazolines; Quinolones; Receptors, Fibroblast Growth Factor; Signal Transduction; Triazines | 2013 |
Finding the optimal combination therapy for the treatment of newly diagnosed AML in older patients unfit for intensive therapy.
Topics: Aminoglycosides; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Critical Care; Cytarabine; Decitabine; Female; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Male; Organophosphates; Quinazolines; Quinolones | 2015 |
Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs.
Topics: Antineoplastic Agents; Drug Discovery; Humans; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Pyridines; Quinazolines; Quinolones; Receptors, Vascular Endothelial Growth Factor; Small Molecule Libraries | 2016 |
Evodiamine: A Privileged Structure with Broad-ranging Biological Activities.
Topics: Alkaloids; Butyrylcholinesterase; Cyclic Nucleotide Phosphodiesterases, Type 5; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Female; Histone Deacetylases; Humans; Quinazolines; Quinolones; Sirtuins; Tubulin | 2022 |
24 other study(ies) available for quinazolines and carbostyril
| Article | Year |
|---|---|
[On the evaluation of the preparation of Chinese medicinal prescriptions. VI. The changes of the alkaloid contents by processing of Evodia fruit].
Topics: Alkaloids; Chromatography, High Pressure Liquid; Drugs, Chinese Herbal; Humans; Indole Alkaloids; Plant Extracts; Quinazolines; Quinolones; Taste | 1991 |
Electrochemical evaluation of the interaction between ascorbic acid and the cardiotonic drug RS-82856.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Ascorbic Acid; Cardiotonic Agents; Drug Interactions; Electrochemistry; Platelet Aggregation Inhibitors; Quinazolines; Quinolones; Solutions | 1987 |
Inhibitors of cyclic AMP phosphodiesterase. 1. Analogues of cilostamide and anagrelide.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Blood Platelets; Humans; Indicators and Reagents; Magnetic Resonance Spectroscopy; Mass Spectrometry; Myocardium; Quinazolines; Quinolines; Quinolones; Rats; Spectrophotometry, Infrared; Structure-Activity Relationship | 1987 |
Cyclic nucleotide phosphodiesterase inhibitors prevent aggregation of human platelets by raising cyclic AMP and reducing cytoplasmic free calcium mobilization.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Alprostadil; Aminoquinolines; Blood Platelets; Calcium; Cyclic AMP; Cytoplasm; Humans; Isoquinolines; Phthalazines; Platelet Aggregation; Quercetin; Quinazolines; Quinolines; Quinolones; Tetrahydroisoquinolines | 1987 |
Inhibitors of cyclic nucleotide phosphodiesterase isozymes block renal tubular cell proliferation induced by folic acid.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cell Division; Cilostazol; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Down-Regulation; Folic Acid; Isoenzymes; Kidney Tubules; Male; Phosphodiesterase Inhibitors; Proliferating Cell Nuclear Antigen; Pyrrolidinones; Quinazolines; Quinolones; Rats; Rats, Sprague-Dawley; Rolipram; Signal Transduction; Tetrazoles | 1997 |
Comparative efficacy of anticoccidials under the conditions of commercial broiler production and in battery trials.
Topics: Animal Husbandry; Animals; Chickens; Clopidol; Coccidiosis; Coccidiostats; Drug Resistance; Eimeria; Feces; Food Industry; Ionophores; Monensin; Nicarbazin; Piperidines; Poultry Diseases; Predictive Value of Tests; Pyrans; Quinazolines; Quinazolinones; Quinolones | 1998 |
In-use testing of extemporaneously prepared suspensions of second generation non-nucleoside reversed transcriptase inhibitors in support of phase I clinical studies.
Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; Clinical Trials, Phase I as Topic; Pharmaceutical Preparations; Quinazolines; Quinazolinones; Quinolones; Reverse Transcriptase Inhibitors; Solubility; Spectrophotometry, Ultraviolet | 2000 |
Expression in yeast and purification of functional recombinant human poly(ADP-ribose)polymerase (PARP). Comparative pharmacological profile with that of the rat enzyme.
Topics: 1-Naphthylamine; Animals; Benzamides; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Gene Expression; Humans; Kinetics; Male; Naphthalimides; Phenanthrenes; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quinazolines; Quinolones; Rats; Recombinant Proteins; Saccharomyces; Sensitivity and Specificity; Testis | 2000 |
Establishment and characterization of acquired resistance to the farnesyl protein transferase inhibitor R115777 in a human colon cancer cell line.
Topics: Alkyl and Aryl Transferases; Antineoplastic Agents; Blotting, Western; Cell Division; Chromones; Colorectal Neoplasms; Drug Resistance, Neoplasm; ErbB Receptors; Farnesyltranstransferase; Humans; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Quinazolines; Quinolones; Transfection; Tumor Cells, Cultured | 2002 |
p38 Inhibitors: piperidine- and 4-aminopiperidine-substituted naphthyridinones, quinolinones, and dihydroquinazolinones.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Biological Availability; Dogs; Enzyme Inhibitors; Half-Life; Macaca mulatta; Mitogen-Activated Protein Kinases; Naphthyridines; p38 Mitogen-Activated Protein Kinases; Piperidines; Quinazolines; Quinolones; Rats; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2003 |
5-imidazolyl-quinolinones, -quinazolinones and -benzo-azepinones as farnesyltransferase inhibitors.
Topics: Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Azepines; Farnesyltranstransferase; Humans; In Vitro Techniques; Indicators and Reagents; Mice; Microsomes, Liver; Quinazolines; Quinolones; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2003 |
Substituted azoloquinolines and -quinazolines as new potent farnesyl protein transferase inhibitors.
Topics: Alkyl and Aryl Transferases; Animals; Cell Division; Drug Design; Enzyme Inhibitors; Farnesyltranstransferase; Kinetics; Molecular Conformation; Molecular Structure; Quinazolines; Quinolines; Quinolones; Structure-Activity Relationship | 2003 |
Identification and characterization of amino-piperidinequinolones and quinazolinones as MCHr1 antagonists.
Topics: Animals; Mice; Quinazolines; Quinolones; Receptors, Pituitary Hormone | 2006 |
A new quinolone and other constituents from the fruits of Tetradium ruticarpum: effects on neutrophil pro-inflammatory responses.
Topics: Anti-Inflammatory Agents; Evodia; Fruit; Humans; Indole Alkaloids; Molecular Structure; Neutrophils; Pancreatic Elastase; Plant Extracts; Quinazolines; Quinolines; Quinolones; Superoxides | 2010 |
Dual inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesis.
Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Agents; Carcinogens; Disease Models, Animal; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; ErbB Receptors; Immunohistochemistry; Mice; Mice, Inbred CBA; Mouth Neoplasms; Neovascularization, Pathologic; Piperidines; Quinazolines; Quinolones; Receptors, Vascular Endothelial Growth Factor | 2010 |
DTI assessment of the brainstem white matter tracts in pediatric BSG before and after therapy: a report from the Pediatric Brain Tumor Consortium.
Topics: Adolescent; Anisotropy; Antineoplastic Agents; Brain Stem; Brain Stem Neoplasms; Child; Child, Preschool; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Diffusion Tensor Imaging; Gefitinib; Glioma; Humans; Image Interpretation, Computer-Assisted; Male; Nerve Fibers, Myelinated; Quinazolines; Quinolones; Radiotherapy | 2011 |
MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Diffusion; Female; Gefitinib; Glioma; Humans; Magnetic Resonance Imaging; Male; Quinazolines; Quinolones; Radiotherapy Dosage; Research Design; Survival Rate; Treatment Outcome | 2011 |
Probing conformational rescue induced by a chemical corrector of F508del-cystic fibrosis transmembrane conductance regulator (CFTR) mutant.
Topics: Aminophenols; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; HEK293 Cells; Humans; Mutation; Piperazines; Protein Binding; Protein Folding; Protein Structure, Tertiary; Quinazolines; Quinolones | 2011 |
Annual drug update: 2011 in review.
Topics: Abatacept; Aminoglycosides; Carbamates; Drug Approval; Fentanyl; Fidaxomicin; Humans; Immunoconjugates; Indans; Linagliptin; Phenylenediamines; Proline; Purines; Quinazolines; Quinolones; United States; United States Food and Drug Administration | 2012 |
A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents.
Topics: Animals; Benzamides; Benzimidazoles; Case-Control Studies; Crk-Associated Substrate Protein; Disease Models, Animal; Endothelial Cells; Epidermal Growth Factor; Familial Primary Pulmonary Hypertension; Fibroblast Growth Factor 2; Gefitinib; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Mice; Monocrotaline; Myocytes, Smooth Muscle; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Pulmonary Artery; Pyrimidines; Quinazolines; Quinolones; Rats; Signal Transduction | 2012 |
EGFR and PKC are involved in the activation of ERK1/2 and p90 RSK and the subsequent proliferation of SNU-407 colon cancer cells by muscarinic acetylcholine receptors.
Topics: Calcium; Carbachol; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Enzyme Activation; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Humans; Indoles; Maleimides; Protein Kinase C; Quinazolines; Quinolones; Receptors, Muscarinic; Ribosomal Protein S6 Kinases, 90-kDa; Tyrphostins | 2012 |
Antagonistic effects of indoloquinazoline alkaloids on antimycobacterial activity of evocarpine.
Topics: Alkaloids; Anti-Bacterial Agents; Drug Antagonism; Humans; Mycobacterium tuberculosis; Plant Extracts; Quinazolines; Quinolones; Tuberculosis | 2015 |
Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRAS
Topics: Allosteric Regulation; Animals; Antineoplastic Agents; Caco-2 Cells; Cell Line, Tumor; Drug Design; Humans; Male; Mice, Nude; Molecular Conformation; Mutation; Neoplasms; Piperazines; Proto-Oncogene Proteins p21(ras); Quinazolines; Quinolones; Rats, Wistar; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2020 |
Dual inhibition of FOXM1 and its compensatory signaling pathway decreased the survival of ovarian cancer cells.
Topics: Acetophenones; Benzopyrans; Cell Line, Tumor; Cell Survival; Female; Forkhead Box Protein M1; GTP Phosphohydrolases; Humans; Membrane Proteins; Ovarian Neoplasms; Pyridines; Quinazolines; Quinolones; Signal Transduction; Thiophenes | 2021 |